DK228081A - Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner - Google Patents

Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner

Info

Publication number: DK228081A
Authority: DK; Denmark
Prior art keywords: vaccin; procedure; preparation; viral glycoprotein; glycoprotein antigens
Prior art date: 1980-06-05

Application number

DK228081A

Other languages

Danish (da)

English (en)

Inventor

J Leclerc

J D Rudder

Original Assignee

Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-06-05

Filing date

1981-05-25

Publication date

1981-12-06

1981-05-25 Application filed by Synthelabo filed Critical Synthelabo

1981-12-06 Publication of DK228081A publication Critical patent/DK228081A/da

Links

102000003886 Glycoproteins Human genes 0.000 title 1
108090000288 Glycoproteins Proteins 0.000 title 1
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
230000003612 virological effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK228081A 1980-06-05 1981-05-25 Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner DK228081A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8012522A FR2483779A1 (fr)	1980-06-05	1980-06-05	Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins

Publications (1)

Publication Number	Publication Date
DK228081A true DK228081A (da)	1981-12-06

Family

ID=9242745

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK228081A DK228081A (da)	1980-06-05	1981-05-25	Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner

Country Status (19)

Country	Link
US (1)	US4344935A (de)
EP (1)	EP0041880B1 (de)
JP (1)	JPS5726624A (de)
AR (1)	AR228865A1 (de)
AT (1)	ATE3239T1 (de)
AU (1)	AU546088B2 (de)
CA (1)	CA1174598A (de)
DE (1)	DE3160264D1 (de)
DK (1)	DK228081A (de)
ES (1)	ES8203225A1 (de)
FI (1)	FI811685L (de)
FR (1)	FR2483779A1 (de)
GR (1)	GR74610B (de)
IE (1)	IE51226B1 (de)
IL (1)	IL62913A (de)
NO (1)	NO811873L (de)
NZ (1)	NZ197306A (de)
PT (1)	PT73032B (de)
ZA (1)	ZA813479B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4721675A (en) *	1982-02-01	1988-01-26	Abbott Laboratories	Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system
US4645666A (en) *	1982-06-08	1987-02-24	The Regents Of The University Of California	Vaccine for bluetongue disease employing platinum compounds
GB8502096D0 (en) *	1985-01-28	1985-02-27	Medical Res Council	Influenza vaccine
NZ224422A (en)	1987-05-05	1990-11-27	Molecular Eng Ass	Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US4909940A (en) *	1987-12-30	1990-03-20	New York Blood Center, Inc.	Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US4975119A (en) *	1989-04-25	1990-12-04	Rheox, Inc.	Liquid antisettling agents for organic coating compositions
US5741493A (en) *	1991-01-24	1998-04-21	Pasteur Merieux Serums Et Vaccins	Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive
FR2671974A1 (fr) *	1991-01-24	1992-07-31	Pasteur Merieux Serums Vacc	Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.
US6780630B1 (en) *	1992-07-10	2004-08-24	Baylor College Of Medicine	Parenteral immunization against rotavirus
FR2723740B1 (fr) *	1994-08-16	1996-11-08	Pasteur Merieux Serums Vacc	Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
DE69629812T2 (de)	1995-06-14	2004-04-01	Baylor College Of Medicine, Houston	Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
US6673355B1 (en)	1995-06-14	2004-01-06	Baylor College Of Medicine	Rotavirus enterotoxin NSP4 and methods of using same
DE19938767C2 (de) *	1999-08-16	2002-10-24	Tad Pharma Gmbh	Spaltimpfstoffe

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE661402A (de)	1964-03-20
US3847737A (en) *	1965-03-22	1974-11-12	A Kanarek	Inactivation of myxoviruses and method of preparing a vaccine therefrom
US3629470A (en) *	1968-04-08	1971-12-21	Burroughs Wellcome Co	Process for purification of animal rna viruses
BR6915288D0 (pt) *	1969-03-15	1973-02-08	Bayer Ag	Processo para a purificacao de solucoes do virus da febre aftosa
US3989818A (en) *	1970-08-14	1976-11-02	South African Inventions Development Corporation	Influenza virus vaccine
US3790552A (en) *	1972-03-16	1974-02-05	Us Health	Method of removing hepatitis-associated antigen from a protein fraction using polyethylene glycol
US3962421A (en) *	1973-06-18	1976-06-08	American Home Products Corporation	Method for the disruption of lipid-containing viruses
GB1486557A (en)	1973-10-18	1977-09-21	Flockhart & Co	Process for the preparation of pyrogen-free sub-unit vaccine
US3951937A (en) *	1973-12-20	1976-04-20	The Community Blood Council Of Greater New York, Inc.	Large scale purification of hepatitis type B antigen using polyethylene glycol
US4140762A (en) *	1974-01-14	1979-02-20	Sandoz Ltd.	Influenza sub-unit vaccine
US4064232A (en) *	1974-01-14	1977-12-20	Sandoz Ltd.	Process for isolating the immunogenic components of influenza viruses
AU507149B2 (en)	1975-01-16	1980-02-07	Mount Sinai School Of Medicine Of The City University Of New York, The	Method of influenza immunization
FR2422720A2 (fr)	1977-04-26	1979-11-09	Elf Aquitaine	Separation et purification de proteines par chromatographie
FI66020C (fi) *	1977-09-19	1984-08-10	Merck & Co Inc	Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
DE2750045A1 (de) *	1977-11-09	1979-05-10	Behringwerke Ag	Verfahren zur entfernung von detergentien aus virusantigensuspensionen

1980
- 1980-06-05 FR FR8012522A patent/FR2483779A1/fr active Granted
1981
- 1981-05-11 AR AR285278A patent/AR228865A1/es active
- 1981-05-14 PT PT73032A patent/PT73032B/pt unknown
- 1981-05-19 US US06/265,084 patent/US4344935A/en not_active Expired - Fee Related
- 1981-05-20 IL IL62913A patent/IL62913A/xx unknown
- 1981-05-22 AT AT81400815T patent/ATE3239T1/de not_active IP Right Cessation
- 1981-05-22 EP EP81400815A patent/EP0041880B1/de not_active Expired
- 1981-05-22 DE DE8181400815T patent/DE3160264D1/de not_active Expired
- 1981-05-25 ZA ZA00813479A patent/ZA813479B/xx unknown
- 1981-05-25 DK DK228081A patent/DK228081A/da not_active Application Discontinuation
- 1981-05-26 IE IE1168/81A patent/IE51226B1/en unknown
- 1981-05-27 ES ES502549A patent/ES8203225A1/es not_active Expired
- 1981-05-29 AU AU71170/81A patent/AU546088B2/en not_active Ceased
- 1981-06-01 FI FI811685A patent/FI811685L/fi not_active Application Discontinuation
- 1981-06-02 CA CA000378801A patent/CA1174598A/en not_active Expired
- 1981-06-02 GR GR65127A patent/GR74610B/el unknown
- 1981-06-03 NO NO811873A patent/NO811873L/no unknown
- 1981-06-04 JP JP8504581A patent/JPS5726624A/ja active Pending
- 1981-06-04 NZ NZ197306A patent/NZ197306A/en unknown

Also Published As

Publication number	Publication date
DE3160264D1 (en)	1983-06-16
JPS5726624A (en)	1982-02-12
PT73032B (fr)	1982-07-01
AR228865A1 (es)	1983-04-29
AU546088B2 (en)	1985-08-15
IE51226B1 (en)	1986-11-12
EP0041880A1 (de)	1981-12-16
ES502549A0 (es)	1982-04-01
FR2483779A1 (fr)	1981-12-11
ZA813479B (en)	1982-06-30
US4344935A (en)	1982-08-17
FI811685L (fi)	1981-12-06
IL62913A0 (en)	1981-07-31
GR74610B (de)	1984-06-29
CA1174598A (en)	1984-09-18
NO811873L (no)	1981-12-07
FR2483779B1 (de)	1983-07-22
PT73032A (fr)	1981-06-01
NZ197306A (en)	1984-03-16
ES8203225A1 (es)	1982-04-01
EP0041880B1 (de)	1983-05-11
ATE3239T1 (de)	1983-05-15
IE811168L (en)	1981-12-05
AU7117081A (en)	1981-12-10
IL62913A (en)	1984-08-31

Legal Events

Date	Code	Title	Description
1987-02-16	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
DK497682A (da)	1983-05-10	Fremgangsmaade til fremstilling af 7-oxabicycloheptan- og 7-oxabicycloheptenprostaglandinanaloge
DK228081A (da)	1981-12-06	Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner
DK169986A (da)	1986-10-16	Antigen beslaegtet med glycoproteinet i aids-virus, isaer en praekursor for glycoproteinet, og fremgangsmaade til fremstilling af et saadant antigen
DK44381A (da)	1981-09-30	Fremgangsmaade og saet til fremstilling af taage
DK154763C (da)	1989-06-26	Fremgangsmaade til fremstilling af norfloxacin
DK333183A (da)	1984-01-21	Fremgangsmaade til fremstilling af herpes simplex virusglycoproteiner
DK427281A (da)	1981-09-25	Fremgangsmaade til fremstilling af terapeutiske praeparater
DK340383D0 (da)	1983-07-25	Monoklone igm-antistoffer og fremgangsmade til deres fremstilling
DK364481A (da)	1982-02-19	Fremgangsmaade til fremstilling af caprylolactamer
DK282384A (da)	1984-12-11	Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet
DK165336C (da)	1993-03-29	Koncentrerede stofbloedgoerende midler og fremgangsmaader til deres fremstilling
DK296281A (da)	1982-01-05	Fremgangsmaade til fremstilling af aminocyklopentanonamider
DK166581A (da)	1981-10-16	Fremgangsmaade til fremstilling af peptider
DK155886D0 (da)	1986-04-04	Vaccine og fremgangsmaade til fremstilling af denne
DK579181A (da)	1982-06-30	Fremgangsmaade til fremstilling af diarylthiophener
DK33181A (da)	1981-08-07	Fremgangsmaade til fremstilling af et interferonlignende protein
DK482583D0 (da)	1983-10-20	Dna-sekvens, dna-strukturer og fremgangsmade til fremstilling af penicillin-acylase under anvendelse deraf
DK188181A (da)	1981-10-30	Fremgangsmaade til fremstilling af halogenerede steroider
DK467181A (da)	1982-04-24	Virusmutant af shv, vaccine indeholdende denne mutant og fremgangsmaade til fremstilling af vaccinen
DK47681A (da)	1981-08-08	Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK153841C (da)	1989-02-20	Fremgangsmaade til fremstilling af ranitidin
DK12581A (da)	1981-07-18	Fremgangsmaade til fremstilling af kijanimicin
DK273183D0 (da)	1983-06-14	Fremgangsmade til fremstilling af amidiner
DK342981A (da)	1982-02-02	Fremgangsmaade til selektiv fremstilling af m-chloraniliner
DK440281A (da)	1982-04-07	Fremgangsmaade til fremstilling af n-carboxylalkyldipeptider og derivater deraf